Developer of immunetherapeutics for immune-disorders. It offers iPSC-derived thymic cells -based therapeutics to restore normal immune function and treat immunodeficiencies, transplant-related, and autoimmune disorders.
← All startups
Thymmune
SeedDeveloper of immunetherapeutics for immune-disorders. It offers iPSC-derived thymic cells -based therapeutics to restore normal immune function and treat immunodeficiencies, transplant-related, and autoimmune disorders.
About
Institutional investors
Pillar VCNYBC VenturesHHS
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.